174 related articles for article (PubMed ID: 21781264)
1. Molecular pathophysiology of the antiphospholipid syndrome: the role of oxidative post-translational modification of beta 2 glycoprotein I.
Passam FH; Giannakopoulos B; Mirarabshahi P; Krilis SA
J Thromb Haemost; 2011 Jul; 9 Suppl 1():275-82. PubMed ID: 21781264
[TBL] [Abstract][Full Text] [Related]
2. Oxidation of β2-glycoprotein I associates with IgG antibodies to domain I in patients with antiphospholipid syndrome.
Raimondo MG; Pericleous C; Radziszewska A; Borghi MO; Pierangeli S; Meroni PL; Giles I; Rahman A; Ioannou Y
PLoS One; 2017; 12(10):e0186513. PubMed ID: 29049363
[TBL] [Abstract][Full Text] [Related]
3. Post-translational modifications of proteins in antiphospholipid antibody syndrome.
Buttari B; Profumo E; Capozzi A; Saso L; Sorice M; Riganò R
Crit Rev Clin Lab Sci; 2019 Dec; 56(8):511-525. PubMed ID: 31448653
[TBL] [Abstract][Full Text] [Related]
4. Antiphospholipid syndrome: 30 years and our contribution.
Koike T
Int J Rheum Dis; 2015 Feb; 18(2):233-41. PubMed ID: 25524556
[TBL] [Abstract][Full Text] [Related]
5. An allosteric redox switch in domain V of β
Kumar S; Chinnaraj M; Planer W; Zuo X; Macor P; Tedesco F; Pozzi N
J Biol Chem; 2021 Aug; 297(2):100890. PubMed ID: 34197876
[TBL] [Abstract][Full Text] [Related]
6. The J-elongated conformation of β
Ruben E; Planer W; Chinnaraj M; Chen Z; Zuo X; Pengo V; De Filippis V; Alluri RK; McCrae KR; Macor P; Tedesco F; Pozzi N
J Biol Chem; 2020 Jul; 295(31):10794-10806. PubMed ID: 32518155
[TBL] [Abstract][Full Text] [Related]
7. β2-Glycoprotein I/HLA class II complexes are novel autoantigens in antiphospholipid syndrome.
Tanimura K; Jin H; Suenaga T; Morikami S; Arase N; Kishida K; Hirayasu K; Kohyama M; Ebina Y; Yasuda S; Horita T; Takasugi K; Ohmura K; Yamamoto K; Katayama I; Sasazuki T; Lanier LL; Atsumi T; Yamada H; Arase H
Blood; 2015 Apr; 125(18):2835-44. PubMed ID: 25733579
[TBL] [Abstract][Full Text] [Related]
8. Glycopeptide profiling of beta-2-glycoprotein I by mass spectrometry reveals attenuated sialylation in patients with antiphospholipid syndrome.
Kondo A; Miyamoto T; Yonekawa O; Giessing AM; Østerlund EC; Jensen ON
J Proteomics; 2009 Nov; 73(1):123-33. PubMed ID: 19706343
[TBL] [Abstract][Full Text] [Related]
9. Post-translational oxidative modification of β2-glycoprotein I and its role in the pathophysiology of the antiphospholipid syndrome.
Mirarabshahi P; Abdelatti M; Krilis S
Autoimmun Rev; 2012 Sep; 11(11):779-80. PubMed ID: 22240262
[TBL] [Abstract][Full Text] [Related]
10. Clinical relevance of nitrated beta 2-glycoprotein I in antiphospholipid syndrome: Implications for thrombosis risk.
Krilis M; Qi M; Ioannou Y; Zhang JY; Ahmadi Z; Wong JWH; Vlachoyiannopoulos PG; Moutsopoulos HM; Koike T; Sturgess AD; Chong BH; Krilis SA; Giannakopoulos B
J Autoimmun; 2021 Aug; 122():102675. PubMed ID: 34098405
[TBL] [Abstract][Full Text] [Related]
11. β2-Glycoprotein I-Reactive T Cells in Autoimmune Disease.
Rauch J; Salem D; Subang R; Kuwana M; Levine JS
Front Immunol; 2018; 9():2836. PubMed ID: 30619248
[TBL] [Abstract][Full Text] [Related]
12. Beta 2 glycoprotein I and neutrophil extracellular traps: Potential bridge between innate and adaptive immunity in anti-phospholipid syndrome.
Grossi C; Capitani N; Benagiano M; Baldari CT; Della Bella C; Macor P; Tedesco F; Borghi MO; Maugeri N; D'Elios MM; Meroni PL
Front Immunol; 2022; 13():1076167. PubMed ID: 36700193
[TBL] [Abstract][Full Text] [Related]
13. {beta}2 Glycoprotein I ({beta}2GPI) binds platelet factor 4 (PF4): implications for the pathogenesis of antiphospholipid syndrome.
Sikara MP; Routsias JG; Samiotaki M; Panayotou G; Moutsopoulos HM; Vlachoyiannopoulos PG
Blood; 2010 Jan; 115(3):713-23. PubMed ID: 19805618
[TBL] [Abstract][Full Text] [Related]
14. The role of thrombospondin-1 in the pathogenesis of antiphospholipid syndrome.
Patsouras M; Tsiki E; Karagianni P; Vlachoyiannopoulos PG
J Autoimmun; 2020 Dec; 115():102527. PubMed ID: 32709480
[TBL] [Abstract][Full Text] [Related]
15. A peptide that mimics the Vth region of beta-2-glycoprotein I reverses antiphospholipid-mediated thrombosis in mice.
Ostertag MV; Liu X; Henderson V; Pierangeli SS
Lupus; 2006; 15(6):358-65. PubMed ID: 16830882
[TBL] [Abstract][Full Text] [Related]
16. A novel mechanism of thrombosis in antiphospholipid antibody syndrome.
Vlachoyiannopoulos PG; Routsias JG
J Autoimmun; 2010 Nov; 35(3):248-55. PubMed ID: 20638238
[TBL] [Abstract][Full Text] [Related]
17. Atherogenic antiphospholipid antibodies in antiphospholipid syndrome.
Kobayashi K; Lopez LR; Matsuura E
Ann N Y Acad Sci; 2007 Jun; 1108():489-96. PubMed ID: 17894014
[TBL] [Abstract][Full Text] [Related]
18. Characteristics of purified anti-β2GPI IgG N-glycosylation associate with thrombotic, obstetric and catastrophic antiphospholipid syndrome.
Liu T; Han J; Zhang R; Tang Z; Yi G; Gong W; Wan L; Hu Q; Teng J; Liu H; Cheng X; Ye J; Su Y; Sun Y; Shi Y; Gu J; Ren S; Yang C; Shi H
Rheumatology (Oxford); 2022 Mar; 61(3):1243-1254. PubMed ID: 34015111
[TBL] [Abstract][Full Text] [Related]
19. Novel insights into associations of antibodies against cardiolipin and beta2-glycoprotein I with clinical features of antiphospholipid syndrome.
Shovman O; Gilburd B; Barzilai O; Langevitz P; Shoenfeld Y
Clin Rev Allergy Immunol; 2007 Apr; 32(2):145-52. PubMed ID: 17916984
[TBL] [Abstract][Full Text] [Related]
20. Biosensor analysis of beta2-glycoprotein I-reactive autoantibodies: evidence for isotype-specific binding and differentiation of pathogenic from infection-induced antibodies.
Metzger J; von Landenberg P; Kehrel M; Buhl A; Lackner KJ; Luppa PB
Clin Chem; 2007 Jun; 53(6):1137-43. PubMed ID: 17434906
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
